Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
This study has found a novel epigenetic mechanism and a potential therapeutic strategy for AD and related diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“and inhibiting H3K4-specific methyltransferases, including MLL1-4 (also named as KMT2A-D) and SETD1a/b, leads to the substantial recovery of glutamatergic synaptic function in PFC pyramidal neurons, and the significant improvement of memory-related behaviors in mutant Tau transgenic mice 260.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [260]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the selective SGK1 inhibitor GSK650394 decreases Tau hyperphosphorylation, restores synaptic transmission, and ameliorate memory deficits in P301S mice [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“RNA sequencing (RNAseq) of the prefrontal cortex (PFC) of the P301S human Tau transgenic mouse model of dementia has identified Serum and Glucocorticoid-regulated Kinase-1 (Sgk1) as one of the top-ranking upregulated genes [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“SGK1 inhibition lowers pTau and rescues the deficits in synaptic transmission and memory tests in P301S mice [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Indeed, the selective SGK1 inhibitor GSK650394 decreases Tau hyperphosphorylation, restores synaptic transmission, and ameliorate memory deficits in P301S mice [10].”
From Elevated SGK1 increases Tau phosphorylation and microtubule instability in Alzheimer’s patient-derived cortical neurons (2026) · cites this paper as [10]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 3×
“The transgenic mice carrying five familial AD mutations on human amyloid precursor protein (K670N/M671L + I716V + V717I) and human presenilin 1 (M146L + L286V), 5xFAD (27), were a gift from W. E. Van Nostrand (Stony Brook University).”
BackgroundInfluentialAdvancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
The contribution of de novo coding mutations to autism spectrum disorder
Iossifov, I., O’Roak, B. J., Sanders, S. J., Ronemus, M., Krumm, N., Levy, D., Stessman, H. A., Witherspoon, K. T., Vives, L., Patterson, K. E., et al. (2014) · Nature · doi:10.1038/nature13908 · Cited by 2,585
Self-citationSingle-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138 · cited 1×
“Our recent studies have found that H3K4 trimethylation (H3K4me3), a histone mark for gene activation (15), is significantly elevated in human AD postmortem tissues and AD mouse models in prefrontal cortex (PFC), a command center for high-level “executive” functions including working memory and decision-making (16) and…”
BackgroundImmune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
Apoptosis in neurodegenerative disorders
Mattson, M. P. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35040009 · Cited by 1,605 · cited 1×
“Apoptosis is well known to be involved in the neuronal cell death associated with AD (54, 55).”
BackgroundExome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome
Ng, S. B., Bigham, A. W., Buckingham, K. J., Hannibal, M. C., McMillin, M. J., Gildersleeve, H. I., Beck, A. E., Tabor, H. K., Cooper, G. M., Mefford, H. C., et al. (2010) · Nature Genetics · doi:10.1038/ng.646 · Cited by 1,347
ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220
Zhou, Y., Song, W. M., Andhey, P. S., Swain, A., Levy, T., Miller, K. R., Poliani, P. L., Cominelli, M., Grover, S., Gilfillan, S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-019-0695-9 · Cited by 1,150
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
Min, S.-W., Cho, S.-H., Zhou, Y., Schroeder, S., Haroutunian, V., Seeley, W. W., Huang, E. J., Shen, Y., Masliah, E., Mukherjee, C., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.08.044 · Cited by 949
Sgk1-Dependent Stimulation of Cardiac Na+/H+Exchanger Nhe1 by Dexamethasone
Voelkl, J., Pasham, V., Ahmed, M. S. E., Walker, B., Szteyn, K., Kuhl, D., Metzler, B., Alesutan, I., & Lang, F. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350120 · Cited by 857
Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. C., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09340.2002 · Cited by 751
(Patho)physiological Significance of the Serum- and Glucocorticoid-Inducible Kinase Isoforms
Lang, F., Böhmer, C., Palmada, M., Seebohm, G., Strutz-Seebohm, N., & Vallon, V. (2006) · Physiological Reviews · doi:10.1152/physrev.00050.2005 · Cited by 689
Multiple roles of HDAC inhibition in neurodegenerative conditions
Chuang, D.-M., Leng, Y., Marinova, Z., Kim, H.-J., & Chiu, C.-T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.002 · Cited by 676
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rao, R. C., & Dou, Y. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3929 · Cited by 669
DNA damage and its links to neurodegeneration
Madabhushi, R., Pan, L., & Tsai, L.-H. (2014) · Neuron · doi:10.1016/j.neuron.2014.06.034 · Cited by 654
Gong, C.-X., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 644 · cited 2×
“Since Sgk1 is capable of phosphorylating the microtubuleassociated protein tau (37), which might contribute to tau hyperphosphorylation, a pathological hallmark of AD (38, 39), we evaluated the effect of Sgk1 inhibitor on hyperphosphorylated tau.”
BackgroundResultEnhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity
Sorrentino, V., Romani, M., Mouchiroud, L., Beck, J. S., Zhang, H., D’Amico, D., Moullan, N., Potenza, F., Schmid, A. W., Rietsch, S., et al. (2017) · Nature · doi:10.1038/nature25143 · Cited by 630
Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease
Gjoneska, E., Pfenning, A. R., Mathys, H., Quon, G., Kundaje, A., Tsai, L.-H., & Kellis, M. (2015) · Nature · doi:10.1038/nature14252 · Cited by 576
Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression
Bai, B., Wang, X., Li, Y., Chen, P.-C., Yu, K., Dey, K. K., Yarbro, J. M., Han, X., Lutz, B. M., Rao, S., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.015 · Cited by 565
Yuen, E. Y., Wei, J., Liu, W., Zhong, P., Li, X., & Yan, Z. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.033 · Cited by 558
Self-citationGreer, E. L., Maures, T. J., Hauswirth, A. G., Green, E. M., Leeman, D. S., Maro, G. S., Han, S., Banko, M. R., Gozani, O., & Brunet, A. (2010) · Nature · doi:10.1038/nature09195 · Cited by 543
Wang, J.-Z., Xia, Y.-Y., Grundke-Iqbal, I., & Iqbal, K. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129031 · Cited by 532 · cited 1×
“05; t test], consistent with prior reports (38, 41).”
ResultPotassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities
Shieh, C.-C., Coghlan, M., Sullivan, J. P., & Gopalakrishnan, M. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01469-8 · Cited by 518
Converging pathways in neurodegeneration, from genetics to mechanisms
Gan, L., Cookson, M. R., Petrucelli, L., & La Spada, A. R. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0237-7 · Cited by 479
Wu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., Srinivasan, K., Huntley, M. A., Wang, Y., Wang, T.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.060 · Cited by 466
Roles of Nuclear Factor κB in Neuronal Survival and Plasticity
Mattson, M. P., Culmsee, C., Yu, Z., & Camandola, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740443.x · Cited by 457
Epigenetic Regulation in Neurodegenerative Diseases
Berson, A., Nativio, R., Berger, S. L., & Bonini, N. M. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.05.005 · Cited by 387
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Jensen, L. R., Amende, M., Gurok, U., Moser, B., Gimmel, V., Tzschach, A., Janecke, A. R., Tariverdian, G., Chelly, J., Fryns, J.-P., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/427563 · Cited by 373 · cited 1×
“Consistently, genetic studies have revealed the prominent link of mutations in H3K4 methyltransferases or demethylases to diseases with cognitive impairment (10), including Wiedemann-Steiner syndrome (KMT2A mutations) (11), Kabuki syndrome (KMT2D mutations) (12), X-linked Claes-Jensen syndrome (KDM5C mutations) (13),…”
BackgroundEpigenetic regulation of gene expression in physiological and pathological brain processes
Gräff, J., Kim, D., Dobbin, M. M., & Tsai, L.-H. (2011) · Physiological Reviews · doi:10.1152/physrev.00012.2010 · Cited by 373
Presynaptic glutamate receptors: physiological functions and mechanisms of action
Pinheiro, P. S., & Mulle, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2379 · Cited by 369
Obulesu, M., & Lakshmi, M. J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1454-4 · Cited by 292 · cited 1×
“Apoptosis is well known to be involved in the neuronal cell death associated with AD (54, 55).”
BackgroundEpigenetic principles and mechanisms underlying nervous system functions in health and disease
MEHLER, M. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.10.001 · Cited by 291
Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators
Duffney, L. J., Zhong, P., Wei, J., Matas, E., Cheng, J., Qin, L., Ma, K., Dietz, D. M., Kajiwara, Y., Buxbaum, J. D., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.064 · Cited by 281
Self-citationDe Novo Mutations in MLL Cause Wiedemann-Steiner Syndrome
Jones, W. D., Dafou, D., McEntagart, M., Woollard, W. J., Elmslie, F. V., Holder-Espinasse, M., Irving, M., Saggar, A. K., Smithson, S., Trembath, R. C., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.06.008 · Cited by 278
Glutamatergic systems in Alzheimer's disease
Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 242
Structural basis for activity regulation of MLL family methyltransferases
Li, Y., Han, J., Zhang, Y., Cao, F., Liu, Z., Li, S., Wu, J., Hu, C., Wang, Y., Shuai, J., et al. (2016) · Nature · doi:10.1038/nature16952 · Cited by 242
Qin, L., Ma, K., Wang, Z.-J., Hu, Z., Matas, E., Wei, J., & Yan, Z. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0110-8 · Cited by 240
Self-citationMechanisms of Mitochondrial Dysfunction in Alzheimer’s Disease
Cadonic, C., Sabbir, M. G., & Albensi, B. C. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9515-5 · Cited by 226
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
Chang, E. H., Savage, M. J., Flood, D. G., Thomas, J. M., Levy, R. B., Mahadomrongkul, V., Shirao, T., Aoki, C., & Huerta, P. T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507313103 · Cited by 225
Sherk, A. B., Frigo, D. E., Schnackenberg, C. G., Bray, J. D., Laping, N. J., Trizna, W., Hammond, M., Patterson, J. R., Thompson, S. K., Kazmin, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1047 · Cited by 211
DNA repair factor BRCA1 depletion occurs in Alzheimer brains and impairs cognitive function in mice
Suberbielle, E., Djukic, B., Evans, M., Kim, D. H., Taneja, P., Wang, X., Finucane, M., Knox, J., Ho, K., Devidze, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9897 · Cited by 202
Rémy, F., Mirrashed, F., Campbell, B., & Richter, W. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.10.045 · Cited by 200
Maillet, D., & Rajah, M. N. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.11.001 · Cited by 172
Cytoskeletal pathologies of Alzheimer disease
Bamburg, J. R., & Bloom, G. S. (2009) · Cell Motility · doi:10.1002/cm.20388 · Cited by 171
Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease
Zheng, Y., Liu, A., Wang, Z.-J., Cao, Q., Wang, W., Lin, L., Ma, K., Zhang, F., Wei, J., Matas, E., et al. (2019) · Brain · doi:10.1093/brain/awy354 · Cited by 168
Self-citationBarnes Maze Testing Strategies with Small and Large Rodent Models
Rosenfeld, C. S., & Ferguson, S. A. (2014) · Journal of Visualized Experiments · doi:10.3791/51194 · Cited by 167 · cited 1×
“Barnes maze test was used to measure spatial memory, as previously described (30, 69).”
MethodRegulation of histone H3K4 methylation in brain development and disease
Shen, E., Shulha, H., Weng, Z., & Akbarian, S. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0514 · Cited by 163 · cited 3×
“6B, the level of S202/T205p-tau and S214p-tau (a direct target of Sgk1) (40) was markedly higher in PFC of AD human postmortem tissue [n = 6 pairs; S202/T205p-tau, t(10) = 4.”
BackgroundKwapis, J. L., Alaghband, Y., Kramár, E. A., López, A. J., Vogel Ciernia, A., White, A. O., Shu, G., Rhee, D., Michael, C. M., Montellier, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05868-0 · Cited by 160
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5
Senisterra, G., Wu, H., Allali-Hassani, A., Wasney, G. A., Barsyte-Lovejoy, D., Dombrovski, L., Dong, A., Nguyen, K. T., Smil, D., Bolshan, Y., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121280 · Cited by 159
Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease
Tracy, T. E., & Gan, L. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2018.04.027 · Cited by 146
From cellular senescence to Alzheimer’s disease: The role of telomere shortening
Boccardi, V., Pelini, L., Ercolani, S., Ruggiero, C., & Mecocci, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.04.003 · Cited by 121
Garrido, G. E. J. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.5.508 · Cited by 93
Sgk1, a cell survival response in neurodegenerative diseases
Schoenebeck, B., Bader, V., Zhu, X., Schmitz, B., Lübbert, H., & Stichel, C. C. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.017 · Cited by 92
Wang, Z.-J., Zhong, P., Ma, K., Seo, J.-S., Yang, F., Hu, Z., Zhang, F., Lin, L., Wang, J., Liu, T., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0351-2 · Cited by 82
Self-citationGenome-wide approaches reveal EGR1-controlled regulatory networks associated with neurodegeneration
Koldamova, R., Schug, J., Lefterova, M., Cronican, A. A., Fitz, N. F., Davenport, F. A., Carter, A., Castranio, E. L., & Lefterov, I. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.005 · Cited by 75
Rapanelli, M., Tan, T., Wang, W., Wang, X., Wang, Z.-J., Zhong, P., Frick, L., Qin, L., Ma, K., Qu, J., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-019-0498-x · Cited by 74
Self-citationChun, J., Kwon, T., Lee, E. J., Kim, C. H., Han, Y. S., Hong, S.-K., Hyun, S., & Kang, S. S. (2004) · Molecules and Cells · doi:10.1016/s1016-8478(23)13125-6 · Cited by 73
Histone lysine methylation: critical regulator of memory and behavior
Jarome, T. J., & Lubin, F. D. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0008 · Cited by 69 · cited 3×
“Histone methylation is uniquely suitable to be part of the molecular underpinnings of memory storage because of its tight association with distinct transcriptional states of genes and its active regulation during memory processes (8, 9).”
BackgroundInfluentialYang, Y. C., Lin, C. H., & Lee, E. H. Y. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01017-06 · Cited by 59
Histone H3 lysine methylation in cognition and intellectual disability disorders
Parkel, S., Lopez-Atalaya, J. P., & Barco, A. (2013) · Learning & Memory · doi:10.1101/lm.029363.112 · Cited by 58
The cell survival kinase SGK 1 and its targets FOXO 3a and NDRG 1 in aged human brain
Sahin, P., McCaig, C., Jeevahan, J., Murray, J. T., & Hainsworth, A. H. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12023 · Cited by 57
Canal, M., RomanÃ-Aumedes, J., MartÃn-Flores, N., Pérez-Fernández, V., & Malagelada, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00313 · Cited by 56
Lin, L., Liu, A., Li, H., Feng, J., & Yan, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190190 · Cited by 18
Self-citation
Cited by
Epigenetic regulation of aging: implications for interventions of aging and diseases
Wang, K., Liu, H., Hu, Q., Wang, L., Liu, J., Zheng, Z., Zhang, W., Ren, J., Zhu, F., & Liu, G.-H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01211-8 · Cited by 663
“In a mouse model of Alzheimer’s disease (AD), the level of H3K4me3 and its catalyzing enzymes increases in the prefrontal cortex, a crucial brain region impaired in AD, and treating these mice with an inhibitor of H3K4 HMTs promotes the recovery of prefrontal cortex functions.(66) The H3K4me3 level has also been shown…”
BackgroundAging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
The role of histone modifications: from neurodevelopment to neurodiseases
Park, J., Lee, K., Kim, K., & Yi, S.-J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01078-9 · Cited by 297
“Administration of a specific Sgk1 inhibitor reduces a hyperphosphorylated tau protein, restores glutamatergic synaptic function, and ameliorates memory deficits in AD mice.(187) H3K9me2 is associated with transcriptional repression.”
BackgroundYan, Z., & Rein, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01092-3 · Cited by 300
“On the other hand, the elevation of permissive histone mark H3K4me3 in AD leads to the upregulation of genes involved in cell stress, such as serum- and glucocorticoid-inducible kinase 1 (SGK1), resulting in hyperphosphorylation of tau, disintegration of microtubules, and disruption of vital protein transport [260].”
BackgroundSelf-citationMethylation across the central dogma in health and diseases: new therapeutic strategies
Liu, R., Zhao, E., Yu, H., Yuan, C., Abbas, M. N., & Cui, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01528-y · Cited by 165
Metadata
- Authors
- Cao, Q., Wang, W., Williams, J. B., Yang, F., Wang, Z.-J., & Yan, Z.
- Affiliations
- University at Buffalo, State University of New York (US)
- Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
- Corresponding author
- Yan, Zhen
- Venue
- Science Advances
- Published
- 2020-12-11
- Volume
- 6
- Issue
- 50
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC7725456
- OpenAlex
- W3111509032
- Cited by
- 108
- References
- 73
- Citations by year
- 2026: 19 · 2025: 20 · 2024: 23 · 2023: 21 · 2022: 17 · 2021: 8
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AG064656, AG056060, AG067597)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- histone H3 lysine 4 trimethylation, Alzheimer's disease, SGK1, SGK1 inhibitor, tau hyperphosphorylation, prefrontal cortex, memory impairment, epigenetic therapy, cognitive impairment
- MeSH terms
- Alzheimer Disease, Animals, Cognition, Disease Models, Animal, Histones, Humans, tau Proteins, Epigenesis, Genetic, Intracellular Signaling Peptides and Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.